A study on optimization of the CAR-γδ T cell manufacturing process
Background and purpose: In recent years, chimeric antigen receptor T (CAR-T) cell therapy has achieved breakthrough progress in cancer treatment. γδ T cells, with their non-major histocompatibility complex (MHC)-restricted antigen recognition, broad antitumor activity, and low risk of graft-versus-h...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Editorial Office of China Oncology
2025-11-01
|
| Series: | Zhongguo aizheng zazhi |
| Assuntos: | |
| Acceso en liña: | http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2025.11.004 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|